These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 20851824

  • 1. Pre-clinical detection of amiodarone-induced acute fibrosing alveolitis by intra-thoracic impedance monitor of an implantable cardioverter-defibrillator.
    Hsieh YC, Huang JL, Chin CS, Lin TC, Liao YC, Ting CT, Wu TJ.
    Europace; 2011 Jan; 13(1):137-9. PubMed ID: 20851824
    [Abstract] [Full Text] [Related]

  • 2. Long-term comparison of the implantable cardioverter defibrillator versus amiodarone: eleven-year follow-up of a subset of patients in the Canadian Implantable Defibrillator Study (CIDS).
    Bokhari F, Newman D, Greene M, Korley V, Mangat I, Dorian P.
    Circulation; 2004 Jul 13; 110(2):112-6. PubMed ID: 15238454
    [Abstract] [Full Text] [Related]

  • 3. Role of amiodarone or implantable cardioverter/defibrillator in patients with atrial fibrillation and heart failure.
    Singh SN, Poole J, Anderson J, Hellkamp AS, Karasik P, Mark DB, Lee KL, Bardy GH, SCD-HeFT Investigators.
    Am Heart J; 2006 Nov 13; 152(5):974.e7-11. PubMed ID: 17070171
    [Abstract] [Full Text] [Related]

  • 4. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.
    Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp-Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH, Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators.
    N Engl J Med; 2005 Jan 20; 352(3):225-37. PubMed ID: 15659722
    [Abstract] [Full Text] [Related]

  • 5. Relationship of amiodarone to postoperative complications of transthoracic implantation of automatic implantable cardioverter defibrillators.
    Calkins H, Bahu M, Shyr Y, Schork A, Bolling S, Kou W, Kirsch M, Morady F.
    Panminerva Med; 1996 Jun 20; 38(2):89-97. PubMed ID: 8979740
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The Midlands Trial of Empirical Amiodarone versus Electrophysiology-guided Interventions and Implantable Cardioverter-defibrillators (MAVERIC): a multi-centre prospective randomised clinical trial on the secondary prevention of sudden cardiac death.
    Lau EW, Griffith MJ, Pathmanathan RK, Ng GA, Clune MM, Cooper J, Marshall HJ, Forsey PR, Stafford PJ, Gray RG, Skehan JD, Garratt CJ.
    Europace; 2004 Jul 20; 6(4):257-66. PubMed ID: 15172648
    [Abstract] [Full Text] [Related]

  • 8. Letter by Dardas and Aaronson regarding article, "Impact of implantable cardioverter-defibrillator, amiodarone, and placebo on the mode of death in stable patients with heart failure: analysis from the sudden cardiac death in heart failure trial".
    Dardas TF, Aaronson KD.
    Circulation; 2010 Oct 12; 122(15):e486; author reply e487. PubMed ID: 20937985
    [No Abstract] [Full Text] [Related]

  • 9. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study.
    Connolly SJ, Hallstrom AP, Cappato R, Schron EB, Kuck KH, Zipes DP, Greene HL, Boczor S, Domanski M, Follmann D, Gent M, Roberts RS.
    Eur Heart J; 2000 Dec 12; 21(24):2071-8. PubMed ID: 11102258
    [Abstract] [Full Text] [Related]

  • 10. [Canadian Implantable Defibrillator Study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone].
    Della Bella P.
    Ital Heart J Suppl; 2000 Aug 12; 1(8):1070-1. PubMed ID: 10993020
    [No Abstract] [Full Text] [Related]

  • 11. Potential impact of antiarrhythmic drugs versus implantable defibrillators on the management of ventricular arrhythmias: the Midlands trial of empirical amiodarone versus electrophysiologically guided intervention and cardioverter implant registry data.
    Pathmanathan RK, Lau EW, Cooper J, Newton L, Skehan JD, Garratt CJ, Griffith MJ.
    Heart; 1998 Jul 12; 80(1):68-70. PubMed ID: 9764063
    [Abstract] [Full Text] [Related]

  • 12. Fibrosing alveolitis associated with amiodarone.
    Butland RJ, Millard FJ.
    Eur J Respir Dis; 1984 Nov 12; 65(8):616-9. PubMed ID: 6519217
    [Abstract] [Full Text] [Related]

  • 13. Delayed detection of stable ventricular tachycardia in a dual-chamber implantable cardioverter defibrillator: what is the mechanism?
    Strohmer B, Schernthaner C, Pichler M.
    J Cardiovasc Electrophysiol; 2004 Feb 12; 15(2):244-6. PubMed ID: 15028059
    [No Abstract] [Full Text] [Related]

  • 14. [79-year-old patient with dyspnoea and blue skin colour].
    Michalski T.
    Dtsch Med Wochenschr; 2011 Sep 12; 136(37):1845-6. PubMed ID: 21898276
    [No Abstract] [Full Text] [Related]

  • 15. Prevalence of appropriate cardioverter-defibrillator shocks in 1038 consecutive patients with implantable cardioverter-defibrillators.
    Kruger A, Aronow WS, Lai H, Desai H, Singla A, Frishman WH, Cohen M, Sorbera C.
    Am J Ther; 2009 Sep 12; 16(4):323-5. PubMed ID: 19617719
    [Abstract] [Full Text] [Related]

  • 16. Implantable defibrillators and/or amiodarone: alternatives or complementary therapies.
    Dorian P, Newman D, Greene M.
    Int J Clin Pract; 1998 Sep 12; 52(6):425-8. PubMed ID: 9894382
    [Abstract] [Full Text] [Related]

  • 17. High defibrillation threshold at cardioverter defibrillator implantation under amiodarone treatment: favorable effects of D, L-sotalol.
    Boriani G, Biffi M, Frabetti L, Maraschi M, Branzi A.
    Heart Lung; 2000 Sep 12; 29(6):412-6. PubMed ID: 11080321
    [Abstract] [Full Text] [Related]

  • 18. Letter regarding article by Bokhari et al, "Long-term comparison of the implantable cardioverter defibrillator versus amiodarone: eleven-year follow-up of a subset of patients in the Canadian Implantable Defibrillator Study (CIDS)".
    Boriani G, Biffi M, Martignani C.
    Circulation; 2005 Jan 25; 111(3):e26; author reply e26. PubMed ID: 15668348
    [No Abstract] [Full Text] [Related]

  • 19. [A hypertensive patient with atrial fibrillation has increasing dyspnea. Cardiac or pulmonary etiology?].
    Stiefelhagen P.
    MMW Fortschr Med; 2009 Mar 05; 151(10):20. PubMed ID: 19472661
    [No Abstract] [Full Text] [Related]

  • 20. Amiodarone versus implantable cardioverter defibrillator for asymptomatic nonsustained ventricular tachycardia in nonischemic dilated cardiomyopathy.
    Cawley PJ, Al-Khatib SM.
    Am Heart J; 2004 May 05; 147(5):790-1. PubMed ID: 15131532
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.